| CA19952218515 19950419 | Monoclonal antibodies against HIV-1 and vaccines made thereof |
| US 20040241641 A1 | IGG1 monoclonal antibody with anti-HIV neutralizing activity |
| AT20030709690T20030117 | Anti-idiotypic antibody inducing HIV-1 neutralizing antibodies |
| US20040485525 20040318 | Peptides mimicking a cryptic epitope of gp41 HIV-1 |
| US-10590204-B2 | Recombinant human IgM-antibody against cancer cells |
| WO2003046187A1 | Method for producing a recombinant polypeptide |
| WO2002 EP13431 20021128 | Process for the production of polypeptides in mammalian cell culture |
| US20050069979A1 | Cell culture processes |
| AT20050748347T 20050524 | Superloaded liposomes for drug delivery |
| 19160231.7 | Stabilized extracellular domain of CD19 |
